StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.53−0.05 (-3.16%)

Close on Nov 16, 2026Market cap $10.74MP/E –Yield –

Earnings

Vyome's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 18, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.10
Latest guidance
Lowered
Apr 4, 2024 · 2 items

Quarterly results

Revenue and earnings per share from each of Vyome's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 18, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 25, 2026during market hours––-$0.10Release
Q1 FY2026ended Mar 31, 2026May 29, 2026before the open$31.59K–-$0.15Release
Q3 FY2025ended Sep 30, 2025Nov 19, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024during market hours$2.30M+4.5%–Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024during market hours$2.00M-13.0%–Release
Q1 FY2024ended Mar 31, 2024Apr 4, 2024before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023during market hours$2.20M-21.4%–Release
Q2 FY2023ended Jun 30, 2023Aug 7, 2023during market hours$2.30M-20.7%–Release
Q1 FY2023ended Mar 31, 2023May 16, 2023during market hours$2.30M-4.2%–Release
Q3 FY2022ended Sep 30, 2022Nov 14, 2022during market hours$2.80M-24.3%–Release
Q2 FY2022ended Jun 30, 2022Aug 16, 2022after the close$2.90M––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Vyome guided for has been reported

Guidance history

Every forecast Vyome put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Apr 4, 2024operating expenses reductionFY202450%Lowered
Apr 4, 2024lowering operating expensesFY2024$8.00MLowered
Nov 8, 2023reduction in operating expensesFY202440%New
Nov 8, 2023core operating expense reductionsFY202470%New
Nov 8, 2023cost reductionsFY2024$8.00MNew
Nov 8, 2023core operating expense reductionsFY2024$22.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Vyome filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. Update
  5. Update
  6. Update
  7. Results
  8. News
  9. News
  10. News
  11. News
  12. Update
  13. Update
  14. News
  15. News

See a number that looks wrong?